Zhejiang Huakang Pharmaceutical Co Ltd (605077) — Cash Flow Quality Index
Zhejiang Huakang Pharmaceutical Co Ltd (605077) has a Cash Flow Quality Index of 0.55x as of December 2024. Operating cash flow of CN¥146.50 Million is below net income of CN¥268.48 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Zhejiang Huakang Pharmaceutical Co Ltd assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Huakang Pharmaceutical Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Zhejiang Huakang Pharmaceutical Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 605077 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Zhejiang Huakang Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market cap of Zhejiang Huakang Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | CN¥146.50 Million | CN¥268.48 Million | ▼ -67.3% |
| 2023 | 1.67x | CN¥619.47 Million | CN¥371.45 Million | ▲ +95.8% |
| 2022 | 0.85x | CN¥271.98 Million | CN¥319.28 Million | ▼ -23.7% |
| 2021 | 1.12x | CN¥264.32 Million | CN¥236.71 Million | ▲ +2.3% |
| 2020 | 1.09x | CN¥335.24 Million | CN¥307.17 Million | ▲ +4.8% |
| 2019 | 1.04x | CN¥281.31 Million | CN¥270.11 Million | ▲ +47.3% |
| 2018 | 0.71x | CN¥140.97 Million | CN¥199.38 Million | ▼ -50.9% |
| 2017 | 1.44x | CN¥80.56 Million | CN¥55.94 Million | ▼ -55.5% |
| 2016 | 3.24x | CN¥93.02 Million | CN¥28.71 Million | — |